[Impact of sarcopenia on effectiveness of lumbar decompression surgery in patients with lumbar spinal stenosis]
- PMID: 35712933
- PMCID: PMC9240839
- DOI: 10.7507/1002-1892.202202048
[Impact of sarcopenia on effectiveness of lumbar decompression surgery in patients with lumbar spinal stenosis]
Abstract
Objective: To investigate the impact of sarcopenia on effectiveness of lumbar decompression surgery in patients with lumbar spinal stenosis.
Methods: The clinical data of 50 patients with lumbar spinal stenosis who met the selection criteria between August 2017 and December 2020 were retrospectively analyzed. According to the diagnostic criteria of the European Working Group on Sarcopenia in Older People (EWGSOP), based on the calculation of the skeletal muscle index (SMI) at the L 3 level, SMI<45.4 cm 2/m 2 (men) and SMI<34.4 cm 2/m 2 (women) were used as the diagnostic threshold, the patients were divided into sarcopenia group (25 cases) and non-sarcopenia group (25 cases). There was no significant difference in gender, age, disease duration, level of lumbar spinal stenosis, surgical fusion level, and comorbidity between the two groups ( P>0.05); the body mass index in sarcopenia group was significantly lower than that in non-sarcopenia group ( t=-3.198, P=0.002). Clinical data of the two groups were recorded and compared, including operation time, intraoperative blood loss, postoperative drainage volume, hospitalization stay, and complications. The visual analogue scale (VAS) scores of low back pain and sciatica and Oswestry disability index (ODI) scores were recorded preoperatively and at last follow-up. The effectiveness was evaluated according to modified MacNab standard.
Results: There was no significant difference between the two groups in terms of operation time, intraoperative blood loss, and postoperative drainage volume ( P>0.05). However, the hospitalization stay in sarcopenia group was significantly longer than that in non-sarcopenia group ( t=2.105, P=0.044). The patients were followed up 7-36 months (mean, 29.7 months). In sarcopenia group, 1 case of dural tear and cerebrospinal fluid leakage occurred during operation, as well as 1 case of internal fixator loosening during follow-up; 1 case of incision exudation and poor healing occurred in each of the two groups, and no adjacent segment degeneration and deep vein thrombosis of lower extremity occurred in the two groups during follow-up. There was no significant difference in the incidence of complications (12% vs. 4%) between the two groups ( χ 2=1.333, P=0.513). VAS scores in low back pain and sciatica as well as ODI scores in two groups significantly improved when compared with preoperative results at last follow-up ( P<0.05). The differences of VAS scores in low back pain and ODI scores before and after operation in sarcopenia group were significantly lower than that in non-sarcopenia group ( P<0.05). However, there was no significant difference of that in VAS scores of sciatica between the two groups ( t=-1.494, P=0.144). According to the modified MacNab standard, the excellent and good rate of the sarcopenia group was 92%, and that of the non-sarcopenia group was 96%, showing no significant difference between the two groups ( χ 2 =1.201, P=0.753).
Conclusion: Patients with sarcopenia and lumbar spinal stenosis may have longer postoperative recovery time, and the effectiveness is worse than that of non-sarcopenic patients. Therefore, for elderly patients with lumbar spine disease, it is suggested to improve preoperative assessment of sarcopenia, which can help to identify patients with sarcopenia at risk of poor surgical prognosis in advance, so as to provide rehabilitation guidance and nutritional intervention in the perioperative period.
目的: 探究肌肉减少症(简称肌少症)对传统腰椎后路开放手术治疗腰椎管狭窄症患者临床疗效的影响。.
方法: 回顾分析2017年8月—2020年12月符合选择标准的50例腰椎管狭窄症患者临床资料,依据欧洲老年人肌少症工作组(EWGSOP)的诊断标准,基于计算L 3水平骨骼肌指数(skeletal muscle index,SMI),以SMI<45.4 cm 2/m 2(男性)和SMI>34.4 cm 2/m 2(女性)作为诊断阈值分为肌少症组(25例)和非肌少症组(25例)。两组患者性别、年龄、病程、腰椎管狭窄节段、手术融合节段、合并症等一般资料比较差异均无统计学意义( P>0.05);肌少症组患者身体质量指数明显低于非肌少症组,差异有统计学意义( t=−3.198, P=0.002)。记录并比较两组患者手术时间、术中出血量、术后引流量、住院时间、并发症,术前及末次随访时腰痛和坐骨神经痛疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI);采用改良MacNab评定标准评价手术疗效。.
结果: 两组手术时间、术中出血量及术后引流量比较差异无统计学意义( P>0.05);肌少症组住院时间显著长于非肌少症组( t=2.105, P=0.044)。两组患者均获随访,随访时间7~36个月,平均29.7个月。肌少症组术中出现硬膜撕裂及脑脊液漏1例、随访期间内固定物松动1例,两组各发生1例切口渗液、愈合不良,随访期间两组均未发生邻近节段退变及下肢深静脉血栓形成;两组并发症发生率(12% vs. 4%)比较差异无统计学意义( χ 2 =1.333, P=0.513)。末次随访时,两组患者腰痛及坐骨神经痛VAS评分和ODI评分均较术前显著改善( P<0.05)。肌少症组患者腰痛VAS评分及ODI评分手术前后差值显著低于非肌少症组( P<0.05),两组坐骨神经痛VAS评分手术前后差值比较差异无统计学意义( t=−1.494, P=0.144)。按照改良MacNab评定标准评价疗效,肌少症组优良率为92%,非肌少症组优良率为96%,两组差异无统计学意义( χ 2=1.201, P=0.753)。.
结论: 与非肌少症患者相比,肌少症合并腰椎管狭窄症患者术后康复时间可能更长,手术临床疗效更差。肌少症需引起脊柱外科医生关注,可通过早期筛查发现有手术预后不良风险的肌少症患者,从而在围术期进行康复指导和营养干预。.
Keywords: Sarcopenia; effectiveness; lumbar spinal stenosis; posterior lumbar surgery.
Conflict of interest statement
利益冲突 在课题研究和文章撰写过程中不存在利益冲突;基金项目经费支持没有影响文章观点和对研究数据客观结果的统计分析及其报道
Similar articles
-
[Early-effectiveness of unilateral biportal endoscopic laminectomy in treatment of two-level lumbar spinal stenosis].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023 Jun 15;37(6):706-712. doi: 10.7507/1002-1892.202302014. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023. PMID: 37331947 Free PMC article. Chinese.
-
[Application of ultrasonic osteotome in the posterior lumbar interbody fusion surgery by unilateral fenestration and bilateral decompression in the treatment of degenerative lumbar spinal stenosis].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Apr 15;33(4):416-422. doi: 10.7507/1002-1892.201808037. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019. PMID: 30983187 Free PMC article. Chinese.
-
[Short-term effectiveness of transforaminal unilateral approach for bilateral decompression in lumbar interbody fusion for the treatment of lumbar spinal stenosis].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 May 15;31(5):519-526. doi: 10.7507/1002-1892.201612131. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017. PMID: 29798539 Free PMC article. Chinese.
-
Effect of the preoperative assessment of the anteroposterior diameters of the spinal canal and dural area on the efficacy of oblique lumbar interbody fusion in patients with lumbar spinal stenosis.J Orthop Surg Res. 2023 Jun 19;18(1):440. doi: 10.1186/s13018-023-03913-3. J Orthop Surg Res. 2023. PMID: 37337281 Free PMC article. Review.
-
Comparison of the results of open PLIF versus UBE PLIF in lumbar spinal stenosis: postoperative adjacent segment instability is lesser in UBE.J Orthop Surg Res. 2023 Jul 29;18(1):543. doi: 10.1186/s13018-023-04038-3. J Orthop Surg Res. 2023. PMID: 37516831 Free PMC article. Review.
Cited by
-
Efficacy of lumbar decompression under large-channel spinal endoscope in elderly patients with segmental lumbar spinal stenosis.J Orthop Surg Res. 2024 Jan 3;19(1):16. doi: 10.1186/s13018-023-04389-x. J Orthop Surg Res. 2024. PMID: 38167077 Free PMC article.
-
Impact of Sarcopenia on Spinal Spondylosis: A Literature Review.J Clin Med. 2023 Aug 19;12(16):5401. doi: 10.3390/jcm12165401. J Clin Med. 2023. PMID: 37629443 Free PMC article. Review.
-
Cervical paraspinal muscle fatty degeneration and postoperative kyphosis after cervical laminoplasty.J Craniovertebr Junction Spine. 2025 Jan-Mar;16(1):81-88. doi: 10.4103/jcvjs.jcvjs_188_24. Epub 2025 Apr 1. J Craniovertebr Junction Spine. 2025. PMID: 40292167 Free PMC article.
-
Impact of sarcopenia on outcomes following lumbar spine surgery for degenerative disease: an updated systematic review and meta-analysis.Eur Spine J. 2024 Sep;33(9):3369-3380. doi: 10.1007/s00586-024-08364-w. Epub 2024 Jun 21. Eur Spine J. 2024. PMID: 38907066
-
The impact of sarcopenia on the incidence of postoperative outcomes following spine surgery: Systematic review and meta-analysis.PLoS One. 2024 Aug 26;19(8):e0302291. doi: 10.1371/journal.pone.0302291. eCollection 2024. PLoS One. 2024. PMID: 39186727 Free PMC article.
References
-
- Derstine BA, Holcombe SA, Goulson RL, et al Quantifying sarcopenia reference values using lumbar and thoracic muscle areas in a healthy population. J Nutr Health Aging. 2017;21(10):180–185. - PubMed
-
-
Ganapathy A, Nieves JW. Nutrition and sarcopenia-what do we know? Nutrients, 2020, 12(6): 1755. doi: 10.3390/nu12061755.
-
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous